Impact of tumor size on survival outcome in metastatic renal cell carcinoma patients (mRCC) treated with targeted therapy.

被引：0
|
作者：
Xie, Wanling
DiNatale, Renzo
Hakimi, A. Ari
Donskov, Frede
Porta, Camillo
Reaume, M. Neil
Basappa, Naveen S.
Hansen, Aaron Richard
Rini, Brian I.
Beuselinck, Benoit
Bjarnason, Georg A.
Srinivas, Sandy
Brugarolas, James
Rha, Sun Young
Wood, Lori
Lalani, Aly-Khan A.
Bosse, Dominick
Duquette, Audrey
Heng, Daniel Yick Chin
Choueiri, Toni K.
机构：
[1] Dana Farber Canc Inst, Boston, MA USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY USA
[3] Aarhus Univ Hosp, Aarhus, Denmark
[4] IRCCS San Matteo Univ Hosp Fdn, Pavia, Italy
[5] Ottawa Hosp Canc Ctr, Ottawa, ON, Canada
[6] Univ Alberta, Cross Canc Inst, Edmonton, AB, Canada
[7] Princess Margaret Canc Ctr, Toronto, ON, Canada
[8] Cleveland Clin, Taussig Canc Inst, Cleveland, OH USA
[9] Univ Hosp Leuven, Leuven Canc Inst, Leuven, Belgium
[10] Univ Toronto, Odette Canc Ctr, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[11] Stanford Univ, Stanford, CA USA
[12] UT Southwestern Med Ctr, Dallas, TX USA
[13] Severance Hosp, Seoul, South Korea
[14] QEII Hlth Sci Ctr, Halifax, NS, Canada
[15] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
[16] Harvard Med Sch, Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期
关键词：
D O I：
10.1200/JCO.2018.36.6_suppl.667
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
667
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Are there geographic differences in the outcome of patients (pts) with metastatic renal cell carcinoma (mRCC) treated with sunitinib (su)?
    Keizman, Daniel
    Ish-Shalom, Maya
    Maimon, Natalie
    Gottfried, Maya
    Pili, Roberto
    Hammers, Hans J.
    Eisenberger, Mario A.
    Sinibaldi, Victoria J.
    Boursi, Ben
    Weitzen, Rony
    Hayat, Henry
    Peer, Avivit
    Neumann, Avivit
    Kovel, Svetlana
    Sella, Avishay
    Mermershtain, Wilmosh
    Roubinov, Keren
    Berger, Raanan
    Carducci, Michael Anthony
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [32] Impact of Serum γ-Glutamyltransferase on Overall Survival in Patients with Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy
    Takemura, Kosuke
    Yuasa, Takeshi
    Inamura, Kentaro
    Amori, Gulanbar
    Koga, Fumitaka
    Board, Philip G.
    Yonese, Junji
    TARGETED ONCOLOGY, 2020, 15 (03) : 347 - 356
  • [33] Impact of Serum γ-Glutamyltransferase on Overall Survival in Patients with Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy
    Kosuke Takemura
    Takeshi Yuasa
    Kentaro Inamura
    Gulanbar Amori
    Fumitaka Koga
    Philip G. Board
    Junji Yonese
    Targeted Oncology, 2020, 15 : 347 - 356
  • [34] Effect of race on survival of metastatic renal cell carcinoma treated with VEGFR-TKI therapy.
    Kuykendal, Adam Rea
    Snavely, Anna C.
    Nielsen, Matthew Edward
    Kim, William Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [35] Tumor response is an independent prognostic factor in patients (pts) treated for metastatic renal cell carcinoma (mRCC)
    Gruenwald, V.
    Lin, X.
    Kalanovic, D.
    McKay, R.
    Perkins, J.
    Simantov, R.
    Choueiri, T.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S642 - S642
  • [36] Impact of tumor size on the outcome of patients with small renal cell carcinoma
    Abdel-Rahman, Omar
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (08) : 769 - 773
  • [37] Characterization of tumor specimens for a targeted therapy in metastatic renal cell carcinoma patients
    Maria Rosaria Raspollini
    Current Oncology Reports, 2007, 9 (5) : 331 - 331
  • [38] Three lines of targeted therapy for metastatic renal cell carcinoma (mRCC): A viable strategy?
    Buchler, Tomas
    Bortlicek, Zbynek
    Poprach, Alexandr
    Kubackova, Katerina
    Kiss, Igor
    Zemanova, Milada
    Fiala, Ondrej
    Abrahamova, Jitka
    Melichar, Bohuslav
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [39] Clinical factors associated with outcome in metastatic renal cell carcinoma patients treated with VEGF-targeted therapy
    Golshayan, A.
    Choueiri, T. K.
    Elson, P.
    Garcia, J. A.
    Khaswneh, M.
    Usman, S.
    Tamaskar, I.
    Wood, L.
    Rini, B. I.
    Bukowski, R. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [40] Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies
    Procopio, G.
    Verzoni, E.
    Iacovelli, R.
    Biasoni, D.
    Testa, I.
    Porcu, L.
    De Braud, F.
    BRITISH JOURNAL OF CANCER, 2012, 107 (08) : 1227 - 1232
12345